Mankind Pharma is an Indian multinational pharmaceutical company headquartered in New Delhi. It is engaged in the development, manufacture and marketing of a broad portfolio of pharmaceutical formulations and consumer healthcare products. The company has a strong presence in the Indian domestic market, particularly across small towns and semi-urban areas, and is widely recognised for its emphasis on affordable medicines.
| Type | Public limited company |
|---|---|
| Industry | Pharmaceuticals, consumer healthcare |
| Founded | 1991 |
| Founders | R. C. Juneja and Rajeev Juneja |
| Headquarters | New Delhi, India |
| Country of origin | India |
| Stock listing | BSE, NSE (listed in 2023) |
Mankind Pharma was established in 1991 by Ramesh Chandra Juneja, who was later joined by his brother Rajeev Juneja. The company began operations on a modest scale and progressively expanded its product range across therapeutic categories such as anti-infectives, gastrointestinal, cardiovascular, anti-diabetic, dermatology, vitamins and minerals, and women's healthcare.
The firm built its growth strategy around price-accessible formulations targeted at Tier II, Tier III and rural markets in India, supported by a large field force of medical representatives. Over time, it expanded into the over-the-counter (OTC) consumer health segment with widely advertised brands in categories such as condoms, emergency contraception, antacids, and personal care.
Mankind Pharma operates manufacturing facilities in multiple Indian states and exports products to several countries across Asia, Africa, the Commonwealth of Independent States (CIS) and Latin America. Its product portfolio spans prescription pharmaceuticals as well as consumer healthcare brands. Notable consumer brands associated with the company include Manforce, Unwanted-72, Prega News, Gas-O-Fast and HealthOK.
The company maintains research and development centres focused on formulation development, generics and select specialty segments. It has progressively widened its work in chronic therapy areas alongside its traditional acute-care strengths.
Mankind Pharma is regarded as one of the largest pharmaceutical companies in India by domestic sales. Its business model—centred on affordable pricing, deep distribution into smaller Indian towns, and aggressive consumer marketing of OTC brands—has been frequently cited as a distinctive case study within the Indian pharmaceutical industry. The 2023 listing made it one of the larger pharmaceutical IPOs in the Indian market.